• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

总睾酮和游离睾酮水平整合用于前列腺癌管理的证据。

Evidence for the integration of total and free testosterone levels in the management of prostate cancer.

机构信息

Department of Urology, Irvine Medical Center, University of California, Orange, CA, USA.

出版信息

BJU Int. 2022 Jul;130(1):76-83. doi: 10.1111/bju.15626. Epub 2021 Nov 19.

DOI:10.1111/bju.15626
PMID:34716982
Abstract

OBJECTIVE

To comprehensively assess total and calculated free testosterone levels in a consecutive group of patients with prostate cancer (PCa) and any potential impact on disease aggressiveness and recurrence outcomes.

PARTICIPANTS AND METHODS

The study included a single-centre prospective cohort of 882 patients presenting for radical prostatectomy from 2009 to 2018. Data on total testosterone (TT), sex hormone-binding globulin (SHBG), and calculated free testosterone (cFT) were prospectively collected. Stepwise logistic regression models were used to assess correlations of TT and cFT with pathological Gleason Grade Group (GGG), extraprostatic extension (EPE), seminal vesicle invasion (SVI) and biochemical recurrence (BCR).

RESULTS

Total testosterone remained nearly constant across decades (40s-80s): 0.09 decrease/year (R = 0.02), while SHBG increased 0.87/year (R = 0.32) and cFT decreased 0.08/year (R = -0.02). Low cFT of <5.5 independently predicted: very-high-risk GGG (odds ratio [OR] 0.435, 95% confidence interval [CI] 0.846-0.994; P = 0.036), EPE (OR 0.557, 95% CI 0.810-0.987; P = 0.011), SVI (OR 0.396, 95% CI 0.798-1.038; P = 0.059), and BCR within 1 year after robot-assisted radical prostatectomy (OR 0.638, 95% CI 0.971-3.512, P = 0.046). TT was not a predictor.

CONCLUSION

In contrast to popular belief, testosterone remained stable in men aged 40-80 years, whereas free testosterone decreased by 2-3%/year. Low cFT was an independent predictor of very-high-risk PCa and BCR.

摘要

目的

全面评估连续一组前列腺癌 (PCa) 患者的总游离睾酮和计算游离睾酮水平,以及其对疾病侵袭性和复发结局的任何潜在影响。

参与者和方法

本研究纳入了 2009 年至 2018 年间因根治性前列腺切除术而就诊的 882 例患者的单中心前瞻性队列。前瞻性收集总睾酮 (TT)、性激素结合球蛋白 (SHBG) 和计算游离睾酮 (cFT) 的数据。逐步逻辑回归模型用于评估 TT 和 cFT 与病理 Gleason 分级组 (GGG)、前列腺外延伸 (EPE)、精囊侵犯 (SVI) 和生化复发 (BCR) 的相关性。

结果

总睾酮在几十年内几乎保持不变 (40 多岁至 80 多岁):每年下降 0.09( R = 0.02),而 SHBG 每年增加 0.87( R = 0.32),cFT 每年下降 0.08( R = -0.02)。cFT<5.5 预测:极高风险 GGG(比值比 [OR] 0.435,95%置信区间 [CI] 0.846-0.994;P = 0.036)、EPE(OR 0.557,95%CI 0.810-0.987;P = 0.011)、SVI(OR 0.396,95%CI 0.798-1.038;P = 0.059) 和机器人辅助根治性前列腺切除术后 1 年内的 BCR(OR 0.638,95%CI 0.971-3.512,P = 0.046)。TT 不是预测因素。

结论

与普遍看法相反,40-80 岁男性的睾酮水平保持稳定,而游离睾酮每年下降 2-3%。低 cFT 是预测极高危 PCa 和 BCR 的独立因素。

相似文献

1
Evidence for the integration of total and free testosterone levels in the management of prostate cancer.总睾酮和游离睾酮水平整合用于前列腺癌管理的证据。
BJU Int. 2022 Jul;130(1):76-83. doi: 10.1111/bju.15626. Epub 2021 Nov 19.
2
Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potential.加权 Gleason 分级组(WGGG):一种具有预后潜力的新前列腺癌活检报告系统。
Urol Oncol. 2020 Mar;38(3):78.e15-78.e21. doi: 10.1016/j.urolonc.2019.10.009. Epub 2019 Dec 1.
3
Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.性激素结合球蛋白是接受根治性前列腺切除术的男性发生囊外扩展的重要预测因子。
BJU Int. 2011 Apr;107(8):1243-9. doi: 10.1111/j.1464-410X.2010.09582.x. Epub 2010 Sep 30.
4
Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer.低循环游离睾酮和生物可利用睾酮水平作为局限性前列腺癌根治性前列腺切除术患者高级别肿瘤的预测指标。
Urol Oncol. 2015 Sep;33(9):384.e21-7. doi: 10.1016/j.urolonc.2014.11.010. Epub 2015 Jan 13.
5
Testosterone replacement therapy reduces biochemical recurrence after radical prostatectomy.睾酮替代疗法可降低根治性前列腺切除术后的生化复发率。
BJU Int. 2020 Jul;126(1):91-96. doi: 10.1111/bju.15042. Epub 2020 Apr 1.
6
Preoperative hypogonadism is not an independent predictor of high-risk disease in patients undergoing radical prostatectomy.术前性腺功能减退症不是行根治性前列腺切除术患者发生高危疾病的独立预测因子。
Cancer. 2011 Sep 1;117(17):3953-62. doi: 10.1002/cncr.25985. Epub 2011 Mar 1.
7
Retrospective Cohort Analysis from a High-Volume Center of Prognostic Factors Affecting Biochemical Relapse in Patients with Encapsulated, Margin-Negative, Isolated Seminal Vesicle Invasion After Robot-Assisted Laparoscopic Prostatectomy: A Novel Study.回顾性队列分析:机器人辅助腹腔镜前列腺切除术后包膜完整、切缘阴性、孤立性精囊侵犯患者生化复发的预后因素——一项新的研究。
J Endourol. 2020 Apr;34(4):441-449. doi: 10.1089/end.2019.0714. Epub 2020 Mar 10.
8
Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?根治性前列腺切除术后的不良病理及超敏前列腺特异性抗原检测不到:是否需要辅助放疗?
BJU Int. 2016 Jun;117(6):897-903. doi: 10.1111/bju.13182. Epub 2015 Jun 23.
9
Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.在局限性前列腺癌中,根治性前列腺切除术标本中的三级Gleason分级模式与下一个更高Gleason评分组相比,预后更差。
Urol Oncol. 2018 Apr;36(4):158.e1-158.e6. doi: 10.1016/j.urolonc.2017.12.003. Epub 2017 Dec 27.
10
Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.预测前列腺癌根治术后生化复发男性前列腺癌特异性死亡率的列线图
Eur Urol. 2015 Jun;67(6):1160-1167. doi: 10.1016/j.eururo.2014.09.019. Epub 2014 Oct 6.

引用本文的文献

1
Systemic lupus erythematosus and prostate cancer risk: a pool of cohort studies and Mendelian randomization analysis.系统性红斑狼疮和前列腺癌风险:队列研究和孟德尔随机化分析的汇总。
J Cancer Res Clin Oncol. 2023 Sep;149(12):9517-9528. doi: 10.1007/s00432-023-04853-5. Epub 2023 May 22.
2
Androgens, aging, and prostate health.雄激素、衰老与前列腺健康。
Rev Endocr Metab Disord. 2022 Dec;23(6):1221-1231. doi: 10.1007/s11154-022-09730-z. Epub 2022 Jun 24.